No wonder Rachel McMinn's AP26113 valuation is ZERO and her ARIA target price was/is $2/$3.
Biotech_Research was right saying she was unprofessional and pathetic at the latest Ariad CC. And No wonder she was unprofessional and pathetic. She might lose her job at BOA.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.